<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing ≤70 kg</article-title>
</title-group>
